Mr. Speaker, that was a very good point raised by my colleague from Cambridge. I know he has a big interest in this file as well and a lot of experience in using natural health products and making them available to his patients in his former career.
I look forward to hearing that information come forward from the minister. I am sure he has done his best to try to remedy this, to make it palatable and make it work better. That is the minister's interest at this time.
I have not seen the fine print or the details of how they propose to do that. I hope it will accomplish the minister's intention. From previous attempts, we were told we had a third category under the Food and Drugs Act, when they simply took the regs and plunked them as a subclass of drugs.
With respect to type II diabetes, we had a big push for aboriginal communities to enhance the diagnosis for type II diabetes on reserve, since that is a federal responsibility. The same day there was an article in the local paper here about a herbal product from native aboriginal history, which turned out to be just as successful as the best drugs in managing type II diabetes. I wonder why we did not choose to promote that approach first in their community, which was a long-standing part of their culture.